Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LEXURE for Post-Stroke Aphasia

NCT: NCT07570264 · RECRUITING

NCT IDNCT07570264
StatusRECRUITING
Start Date2026-04-16
Completion2026-12-30
SponsorNunaps Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑